Beyond infection status: a cross-sectional study of socioeconomic disparities, infection dynamics, and psychosocial burden among women with HPV in Luzhou, China Authors: Jiewei Ming, Huagui Chen, Yuman Li, Xia Wu, Fan Zhang, Dan Nie Published: 2025 ABSTRACT AbstractBackgroundHuman papillomavirus (HPV) infection entails oncologic risk as well as substantial psychosocial and quality-of-life (QoL) burden. data from Southwest China remain limited. This study aims to evaluate anxiety, depression, and quality of life among HPV-positive women in Luzhou, China.MethodsIn this cross-sectional study, 441 HPV-positive women attending two tertiary hospitals (November 2023–September 2024) completed the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and a culturally adapted HPV Impact Profile (HIP). Clinically relevant anxiety and depression were defined as GAD-7 or PHQ-9 ≥ 5 (mild or greater). Multivariate binary logistic regression identified predictors; HIP construct validity was examined using confirmatory factor analysis (CFA).ResultsThe prevalence of anxiety and depression symptoms among HPV-positive women was 40.36% and 41.72%, respectively. The HIP demonstrated excellent internal consistency (Cronbach’s α = 0.946) and acceptable fit (CFI 0.927; RMSEA 0.079). Quality of life analysis indicated the highest domain burden was Worry & Concern (66.73 ± 34.33). Lower monthly income emerged as a protective factor for both anxiety and depression. Key risk predictors for both anxiety and depression included HPV16/18 infection (OR = 3.11; OR = 2.76, respectively), shorter infection duration (OR = 5.77; OR = 7.24, respectively), and higher HIP domain scores (all p < 0.01). Reduced gravidity (≤ 1 pregnancy: OR = 2.832) and parity (≤ 1 birth: OR = 3.889; 2–3 births: OR = 3.056) were identified as specific risk factors for depression. Current smoking showed an inverse association with both anxiety and depression (OR = 0.350; OR = 0.324, respectively), though this requires cautious interpretation. Regression analyses further identified specific psychosocial domains, such as emotional impact and self-image, as significant predictors for these mental health conditions.ConclusionsSubstantial psychosocial and QoL burden accompanies HPV infection in Southwest China, concentrated in worry, emotional distress, body image, relational, and healthcare interaction domains. Early, genotype-informed, culturally adapted psychosocial screening and counseling are warranted.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12905-025-04129-9.Keywords: Human papillomavirus, Psychosocial burden, Anxiety, Depression, Quality of life, Human papillomavirus genotype Background Cervical cancer, primarily caused by persistent high-risk human papillomavirus (HPV) infection, remains a major global health challenge, with an estimated 348,000 deaths in 2022, predominantly affecting low- and middle-income countries [1]. In China, cervical cancer ranks second among female malignancies, with 150,700 new cases and 55,700 deaths reported in 2022 [2]. National strategies (e.g., Accelerated Elimination of Cervical Cancer Action Plan 2023–2030) aim to expand vaccination and screening, yet the psychosocial sequelae of HPV infection receive comparatively less attention. Evidence indicates that HPV-positive women frequently experience anxiety, depressive symptoms, and stigma, which may influence immune modulation, viral persistence, and progression risk [3, 4]. In Southwest China, including the Luzhou region, the cultural stigma surrounding HPV as a sexually transmitted infection may intensify shame, social withdrawal, and delayed treatment-seeking [5–9]. Most existing research emphasizes virology, treatment, or high-resource urban cohorts; fewer studies examine region-specific psychosocial impacts in less-studied Southwestern China regions [10]. Additionally, widely used psychological assessment tools, such as the General Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire (PHQ-9), fail to capture HPV-specific stressors, such as fear of cancer risk or discomfort during gynecological exams [11, 12]. Existing predictive models of HPV-related anxiety and depression overly rely on demographic or clinical variables, neglecting multidimensional quality-of-life domains like sexual impact and partner relationships [13]. These limitations underscore the need for region-specific studies and culturally adapted tools to address the unique psychosocial challenges faced by HPV-infected women. This study estimates the prevalence of anxiety and depression using established symptom thresholds, evaluates the psychometric performance of a culturally adapted HPV Impact Profile (HIP), and identifies socioeconomic, clinical, and psychosocial predictors (e.g., HPV16/18 genotype, infection duration, HIP domains) to inform tailored intervention design for underserved women in Luzhou, Southwest China. Methods Study design and participants This hospital-based cross-sectional survey of HPV-positive women was conducted at two tertiary hospitals in Luzhou, China (November 2023–September 2024). Of 450 distributed questionnaires, 441 were valid (response rate 98.0%). Inclusion criteria: confirmed HPV infection per 2015 Chinese Expert Consensus guidelines [14]; receiving clinical management for lower genital tract HPV infection; communication ability; permanent residency in Luzhou; provision of written informed consent. Exclusion criteria: diagnosed severe psychiatric disorders (e.g., schizophrenia, major depressive disorder under active specialty care); severe physical comorbidities (e.g., other malignancies); pregnancy; or lactation. The selection of study participants adhered to the principles of voluntary participation and informed consent. The study protocol was reviewed and approved by the Ethics Committee of the People's Hospital of Naxi District, Luzhou City (Approval No.20230614KYLL016). Data collection A structured questionnaire captured sociodemographic and behavioral variables (age, residence, education, monthly income, smoking, alcohol use, marital status, age at first intercourse, number of sexual partners, gravidity, parity), HPV genotype, and infection duration (Appendix 1). Anxiety and depression were assessed via GAD-7 (Appendix 2) [15] and PHQ-9 (Appendix 3) [16]. HPV-specific psychosocial impact/QoL was measured using the HPV Impact Profile (HIP) (Appendix 4) [17]. Data were collected via WenJuanXing with on-site trained staff oversight to minimize entry errors and support respondent understanding. Cultural adaptation Bilingual experts reviewed semantic and conceptual equivalence following Brislin’s translation–back-translation framework. A pilot (n = 30) confirmed clarity. Minor lexical adjustments were made to reflect locally meaningful expressions (e.g., “follow-up uncertainty”, “family role pressure”). Scoring and outcome definitions GAD-7 and PHQ-9 were scored using standard 0–3 item responses (range 0–21; 0–27). Symptom severity categories: 0–4 none/minimal; 5–9 mild; 10–14 moderate; 15–19 (PHQ-9 only: moderately severe); ≥15 (GAD-7: severe); ≥20 (PHQ-9: severe). Positive anxiety or depression for prevalence and primary regression was defined as ≥ 5 (any clinically relevant symptoms). A planned sensitivity analysis using ≥ 10 (moderate or worse) will be reported if conducted (not included here). HIP domains (0–100) reflect greater adverse impact with higher scores. Data analysis Data analysis was performed using SPSS 26.0 and AMOS 24.0 (IBM, Armonk, NY). Internal consistency (Cronbach’s α) and confirmatory factor analysis (CFA) assessed HIP reliability and construct validity (fit indices: χ²/df, CFI, RMSEA). Pearson correlations evaluated associations between HIP domains and continuous GAD-7/PHQ-9 scores. Binary logistic regression (entry method) identified predictors of anxiety and depression (dichotomized ≥ 5). Covariate selection was theory-driven (socioeconomic, behavioral, reproductive, clinical, and HIP domains). Multicollinearity was assessed (VIF < 2 threshold); linearity of continuous predictors with logit was inspected (Box–Tidwell). Model calibration (Hosmer–Lemeshow test) and discrimination (AUC) were examined. Missing data (< 5% per variable) were handled by complete-case analysis after confirming MCAR (Little’s test p > 0.05). Two-sided p < 0.05 denotes statistical significance. Results Participant characteristics The sociodemographic and reproductive characteristics are shown in Table 1. The median age of participants was 38 years (range 18–63 years). Most participants resided in urban locations (59.81%) and had a high school education or higher (51.93%). Over half (53.52%) of participants reported a monthly income below $420; 75.96% were married; 77.32% initiated sexual activity at ≥ 18 years. Nearly half reported one lifetime sexual partner (49.43%), with a similar proportion reporting 2–5 partners (48.30%). Additionally, a total of 77.55% participants had been pregnant more than twice, 47.85% had given birth once or fewer, and 46.03% had given birth 2–3 times. Table 1The sociodemographic characteristics of the study participantsVariablesCategoriesCount (n)Percentage (%)Age (years)<2525–40>40232291895.2251.9342.85ResidenceUrbanRural26118059.8140.82Education levelPrimary school and belowJunior highHigh school (including technical secondary or vocational school)College and above871258014919.7328.3418.1433.79Monthly income ($)≤ 140140–420420–695>695961401238221.7731.7527.8918.59SmokingYesNo284136.3593.65Alcohol consumptionYesNo24219954.8845.12Marital statusUnmarriedMarriedDivorced/WidowedRemarried3233564107.2675.9614.512.27Age at first sexual intercourse (years)≤ 18>1810034122.6877.32Number of sexual partners≤ 12–5>52182131049.4348.302.26Number of pregnancies≤ 12–3≥ 49918815422.4542.6334.92Number of births≤ 12–3≥ 42112032747.8546.036.12 The sociodemographic characteristics of the study participants <25 25–40 >40 23 229 189 5.22 51.93 42.85 Urban Rural 261 180 59.81 40.82 Primary school and below Junior high High school (including technical secondary or vocational school) College and above 87 125 80 149 19.73 28.34 18.14 33.79 ≤ 140 140–420 420–695 >695 96 140 123 82 21.77 31.75 27.89 18.59 Yes No 28 413 6.35 93.65 Yes No 242 199 54.88 45.12 Unmarried Married Divorced/Widowed Remarried 32 335 64 10 7.26 75.96 14.51 2.27 ≤ 18 >18 100 341 22.68 77.32 ≤ 1 2–5 >5 218 213 10 49.43 48.30 2.26 ≤ 1 2–3 ≥ 4 99 188 154 22.45 42.63 34.92 ≤ 1 2–3 ≥ 4 211 203 27 47.85 46.03 6.12 HPV infection characteristics The most common HPV genotypes of participants included HPV16 (28.80%), HPV52 (22.68%), HPV58 (13.15%), HPV18 (9.98%), and HPV51 (7.03%; Fig. 1). Persistent HPV infection for ≥ 1 year occurred in 202 participants (45.80%). HPV infection types and their percentages Prevalence of anxiety and depression Overall, 40.36% participants met criteria for anxiety symptoms (≥ 5): mild 24.04%, moderate 8.84%, severe 7.48%. The mean GAD-7 score was 4.60 ± 5.01. Depression symptoms (≥ 5) were present in 41.72% participants: mild 27.21%, moderate 7.26%, moderately severe 4.53%, severe 2.72%. The mean PHQ-9 score was 5.23 ± 5.28 (Table 2). Table 2Anxiety and depression status of the study participantsCategoriesMean score (Mean ± SD)Count (n)Percentage (%)AnxietyMild6.58 ± 1.1010624.04Moderate11.80 ± 1.32398.84Severe16.61 ± 1.27337.48Negative1.24 ± 1.5526359.64DepressionMild7.08 ± 1.8512027.21Moderate11.78 ± 1.56327.26Moderate - Severe17.30 ± 1.34204.53Severe22.08 ± 2.64122.72Negative1.82 ± 1.4925758.28 Anxiety and depression status of the study participants Psychometric validation of the HIP HIP demonstrated excellent internal consistency (total α = 0.946; subscale α range 0.802–0.962). CFA supported acceptable fit: χ²/df = 3.720; CFI = 0.927; RMSEA = 0.079. All standardized factor loadings were > 0.60 (p < 0.001). Discriminant validity was evidenced by square roots of average variance extracted (AVE) exceeding inter-domain correlations (Fig. 2). Confirmatory factor analysis model diagram Quality of Life (QoL) and psychosocial impact (HIP domains) As shown in Table 3, the HIP total score indicated a moderate overall psychosocial/QoL impact. Worry & Concern showed the highest burden (66.73 ± 34.33), followed by Doctor Interaction (47.80 ± 30.08), Self-image (47.56 ± 32.14), Life Impact (47.23 ± 29.44), Sexual Impact (46.50 ± 33.39), Partner Relationship (45.14 ± 32.39), and Emotional Impact (38.05 ± 29.12). Table 3Quality of life and psychosocial impact profiles (HIP domain scores)VariablesScores (Mean ± SD)Worry and Concern66.73 ± 34.33Emotional Impact38.05 ± 29.12Sexual Impact46.50 ± 33.39Self-Image47.56 ± 32.14Partner Relationship45.14 ± 32.39Doctor Interaction47.80 ± 30.08Life Impact47.23 ± 29.44 Quality of life and psychosocial impact profiles (HIP domain scores) Multivariable predictors of anxiety and depression The results of the binary logistic regression analysis of factors associated with anxiety and depression in HPV-infected women are shown in Table 4. Anxiety was associated with higher monthly income ($420–695 vs. >$695; OR = 0.465, 95% CI 0.232–0.932), HPV16/18 genotype (OR = 3.11, 95% CI 1.830–5.288), and shorter infection duration (< 1 year; 1–<2 years; 2–<3 years vs. ≥ 3 years: ORs 5.77, 4.55, 5.94, respectively). Current smoking showed an inverse association (OR = 0.35, 95% CI 0.134–0.914); interpret cautiously due to potential residual confounding (e.g., unmeasured coping styles). Table 4Binary logistic regression analysis of factors associated with anxiety/depression in women with HPVVariablesAnxietyDepressionOR95% CI p OR95% CI p Age (years) <250.6660.098–1.201−1.0670.5520.174–2.548−1.067 25–400.8620.424–1.4690.6380.6510.454–1.6370.638 >401-----Residence Urban1.1140.702–2.0400.5090.7020.642–1.9331.197 Rural1-----Education level Primary school and below0.5050.264–1.8090.4520.1890.182–1.4000.692 Junior high1.4490.819–4.2770.1370.3980.613–3.4261.872 High school (including technical secondary or vocational school)1.0670.583–2.5590.5950.8720.482–2.3641.222 College and above1-----Monthly income ($) ≤ 1400.2890.213–1.2980.1630.0140.108–0.7740.526 140–4200.2630.218–1.1430.1000.0040.106–0.6490.499 420–6950.3650.232–0.9320.0310.0080.173–0.7710.465 >6951-----Smoking Yes0.3240.134–0.9140.0320.0280.119–0.8850.350 No1-----Alcohol consumption Yes0.6760.524–1.4570.6060.1530.395–1.1570.874 No1-----Marital status Unmarried4.5920.617–26.2880.1450.1450.592–35.6424.028 Married3.0110.633–12.1420.1760.1870.587–15.4542.772 Divorced/Widowed2.2830.581–11.2230.2150.3230.445–11.7242.553 Remarried1-----Age at first sexual intercourse (years) ≤ 181.4680.610–1.9480.7710.2240.791–2.7231.090 >181-----Number of sexual partners ≤ 12.4330.211–6.1640.8790.3260.413–14.3391.141 2–51.6550.190–4.8630.9620.5580.307–8.9260.961 >51-----Number of pregnancies ≤ 12.8320.860–5.2730.1020.0341.08–7.4262.130 2–31.1710.638–2.0130.6700.5950.655–2.0931.133 ≥ 41-----Number of births ≤ 13.8890.371–3.5110.8170.0261.178–12.8421.141 2–33.0560.579–4.0290.3920.0321.103–8.4681.527 ≥ 41-----HPV infection type HPV16/182.7591.830–5.2880.00001.588–4.7933.111 Other high-risk HPV1-----Duration (years) ≤ 17.2392.298–14.4710.00002.707–19.3585.767 > 1–220.1611.750–11.8200.00206.962–58.3864.548 > 2–31.9982.085–16.9470.0010.2260.652–6.1165.944 >31-----GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire, OR odds ratio, CI confidence interval Binary logistic regression analysis of factors associated with anxiety/depression in women with HPV GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire, OR odds ratio, CI confidence interval Depression predictors included higher income ($420–695 vs. >$695; OR = 0.365, 95% CI 0.173–0.771), reduced gravidity (≤ 1 pregnancy: OR = 2.832) and parity (≤ 1 birth: OR = 3.889; 2–3 births: OR = 3.056), HPV16/18 genotype (OR = 2.76), and shorter infection duration (< 1 year OR = 7.239; 1–2 years OR = 20.161). Current smoking again showed an inverse association (OR = 0.324). Correlation of HIP domains with symptoms All HIP domains correlated positively with GAD-7 (r = 0.328–0.497, p < 0.01) and PHQ-9 (r = 0.463–0.584, p < 0.01) scores (Table 5). The correlation between the GAD-7 and the Doctor Interaction domain was the highest (r = 0.497). The highest correlations for the PHQ-9 were observed with the Self-Image domain (r = 0.576) and the Partner Relationship domain (r = 0.584). The Worry and Concern domain, which had the highest HIP score, was significantly correlated with both anxiety (r = 0.464) and depression (r = 0.463). Table 5Correlations between the GAD-7/PHQ-9 and each domain of the HIPVariablesGAD-7PHQ-9Worry and Concern0.464**0.463**Emotional Impact0.475**0.502**Sexual Impact0.328**0.465**Self-Image0.446**0.576**Partner Relationship0.439**0.584**Doctor Interaction0.497**0.494**Life Impact0.418**0.532**GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire. ** p < 0.01, * p < 0.05 Correlations between the GAD-7/PHQ-9 and each domain of the HIP GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire. ** p < 0.01, * p < 0.05 Predictors from HIP domains In models incorporating HIP domains (Table 6), anxiety was identified as Worry and Concern (OR = 1.042, p < 0.001), Emotional Impact (OR = 1.064, p < 0.001), and Doctor Interactions (OR = 1.087, p < 0.001). For depression, significant psychosocial risk factors were Worry and Concern (OR = 1.041, p < 0.001), Emotional Impact (OR = 1.055, p < 0.001), Self-Image (OR = 1.054, p = 0.001), and Partner Relationship (OR = 1.091, p < 0.001). Sexual and Life Impact domains were not independently significant after adjustment. Table 6Binary logistic regression analysis of factors influencing anxiety and depressionVariablesGAD-7PHQ-9OR95% CI p OR95% CI p Worry and Concern1.0421.028–1.056< 0.0011.0411.024–1.057< 0.001Emotional Impact1.0641.038–1.090< 0.0011.0551.024–1.086< 0.001Sexual Impact0.9880.935–1.0440.6771.0450.986–1.1070.136Self-Image1.0230.993–1.0550.1321.0541.021–1.0890.001Partner Relationship1.0320.995–1.0710.0891.0911.047–1.136< 0.001Doctor Interaction1.0871.047–1.128< 0.0011.0370.996–1.0800.076Life Impact0.9770.936–1.0190.2731.0060.961–1.0520.801GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire Binary logistic regression analysis of factors influencing anxiety and depression GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire Discussion This study uncovers a high burden of anxiety (40.36%) and depression (41.72%) among HPV-positive women in Luzhou using sensitive (≥ 5) thresholds, exceeding national or general population estimates reported elsewhere [18, 19]. This disparity underscores the profound psychological burden of HPV diagnoses, consistent with Cui et al. [20], a pattern that is now recognized across diverse Asian settings. Studies from Taiwan and Iran have similarly documented intense fear, worry, and stigma upon diagnosis, particularly regarding partner disclosure and privacy concerns [5, 21]. Notably, smokers exhibited 35% and 32.4% lower anxiety and depression risk, respectively, than non-smokers. However, this counterintuitive finding must be interpreted cautiously and likely reflects residual confounding rather than a protective effect. This may reflect nicotine’s transient stress relief as a maladaptive coping mechanism [22, 23], and underscores that smoking is a marker of vulnerability rather than a cause of resilience. Women with higher incomes (>$695/month) face elevated risks, aligning with Qian’s findings on urban pressures and reduced social support [24], while lower-income groups demonstrated resilience through family networks. This socioeconomic pattern differs from that observed in Lebanon, where employment was a protective factor [25], suggesting socioeconomic influences on HPV psychosocial impact are highly culture-specific. Limited reproductive experience (≤ 1 pregnancy) increased depression risk by a factor of 2.8–3.9, driven by fertility concerns [26], which resonates with qualitative research showing that reproductive concerns constitute a primary source of anxiety for HPV-positive women [27]. Regional HPV subtype patterns in Luzhou—HPV16 (28.80%), HPV52 (22.68%), HPV58 (13.15%), HPV18 (9.98%), and HPV51 (7.03%)—align with China’s national data (HPV52/16/58 dominance) [28, 29]. Notably, the HPV16/58 dominance pattern in our study shows parallels with Vientiane data, where HPV16 (20.5%) and HPV58 (9.1%) were the most prevalent subtypes [30], suggesting shared epidemiological patterns across the region. HPV16/18 carriers faced 3.1–2.8 times the anxiety and depression risk than those with other subtypes, while acute infections (< 1 year) were associated with 5.8 times the anxiety risk versus those with chronic infections (>3 years) [31]. The 1–2-year post-diagnosis period marked peak depression vulnerability (OR = 20.1); this finding corroborates longitudinal research from Taiwan showing the highest psychosocial distress occurs within the first 6 months post-diagnosis [32]; this critical window reflects the prolonged effects of diagnostic shock and health-related uncertainty [33–35]. This study validated the HIP in Southwest China, demonstrating cultural applicability (Cronbach’s α = 0.946; RMSEA = 0.079). Unlike general instruments (e.g., GAD-7, PHQ-9) [11, 12], the HIP captures HPV-specific stressors, with Luzhou participants scoring highest on Worry and Concern due to stigma and literacy gaps [36]. Our findings parallel observations from Lebanon, where “concerns and worries” were the most strongly felt psychological impact among HPV-positive women [25]. Key anxiety predictors included HPV-specific fears and poor clinician communication, while depression risk stemmed from self-stigmatization and relationship conflicts [25, 37, 38]. These mechanisms operate across Asian contexts, as Iranian women reported similar experiences of self-blame, negative body image, and healthcare provider stigmatization [5]. Chronic distress may accelerate cervical carcinogenesis via neuroendocrine-immune dysregulation [10], exacerbated by cultural marginalization in conservative regions [8, 9]. Clinician-patient communication quality critically influenced outcomes, with inadequate emotional support during Diagnosis mirroring global trends [39–41]. This finding particularly resonates with Taiwanese research indicating that women actively seek reputable doctors and value privacy during consultations [21]. Effective communication enhances health literacy and treatment adherence, yet remains underprioritized in rural Southwest China. To address these gaps, integrated interventions have been proposed, including digital platforms (e.g., WeChat-based apps for privacy-protected counseling [10]), tiered psychological therapies such as cognitive-behavioral therapy for high-risk groups (HPV16/18, newly diagnosed patients) [42, 43], and culturally tailored education initiatives such as de-stigmatization campaigns (e.g., “HPV ≠ Moral Defect”) paired with grassroots health worker training [44]. These approaches should be particularly considered for neighboring regions like Laos, where detection systems for cervical cancer are still developing [45], and similar psychosocial support needs likely exist, and must account for religious and social factors, as demonstrated in Lebanon, where Muslim women showed a significantly worse impact on key life domains [25]. The WHO advocates integrating counseling into HPV care [45]; yet, current systems neglect mental health support [3]. This neglect is particularly concerning given the documented unmet psychological needs of HPV-positive women across multiple Asian societies [5, 21, 25]. Future studies must evaluate these strategies in Southwest China to address regional inequities, while also considering longitudinal approaches to track psychosocial adjustment over time as implemented in Taiwanese research [32]. Comparative studies with neighboring countries like Laos, which shares similar HPV subtype patterns but may differ in cultural responses to diagnosis, would be particularly valuable [30]. Limitations and future directions This study has several limitations. First, its cross-sectional design precludes causal inference between psychosocial burden and HPV infection dynamics. Second, the sample was confined to women attending tertiary hospitals and primarily those requiring clinical management, potentially inflating distress prevalence and limiting generalizability to community-screened or asymptomatic populations. Exclusion of transient, untreated infections introduces selection bias. Third, reliance on self-report scales may involve recall or social desirability bias (particularly for sensitive domains like sexual impact and partner dynamics). Fourth, we dichotomized GAD-7 and PHQ-9 at ≥ 5 to capture early distress; alternative thresholds (≥ 10) could yield different prevalence estimates—future sensitivity analyses are warranted. Fifth, the cultural adaptation of HIP requires confirmation of measurement invariance across diverse Chinese subpopulations before extrapolation. Finally, other potential variables that influence mental health were not included, which may lead to bias in the results. Future research should employ adequately powered, multicenter, cross‑regional designs to enhance external validity by including a more representative spectrum of HPV‑positive women (those requiring treatment, asymptomatic, and transient/self‑clearing infections), thereby reducing selection bias and more fully capturing the psychosocial burden. A broader set of psychosocial determinants—social support, socioeconomic position, partner relationship quality, healthcare access, perceived stigma, and health literacy—should be systematically collected to elucidate how sociocultural and service environments shape emotional regulation. Methodologically, priorities include: Prospective longitudinal cohorts to establish temporal ordering and test causal and mediation pathways linking HPV diagnosis, infection dynamics (persistence/clearance), and anxiety/depression or HPV‑specific impact. Embedded qualitative studies (in‑depth interviews, focus groups) to contextualize symptom trajectories, coping strategies, and unmet support needs. Development and rigorous evaluation of tailored psychosocial interventions (e.g., stratified counseling, peer support, digital follow‑up) in community or primary care settings using randomized controlled trials or robust quasi‑experimental designs (stepped‑wedge, matched clusters) with concurrent implementation outcomes. Cross‑cultural validation and optimization of measurement instruments (measurement invariance, reliability, construct validity, responsiveness, minimal clinically important difference), with adaptation or short‑form development as needed. Strengthened interdisciplinary collaboration (medicine, psychology, sociology, implementation science) integrating biological markers (HPV genotype, persistence), psychometrics, and social network or service utilization data to build multilevel predictive and intervention models. These advances will shift the field from descriptive epidemiology toward mechanism clarification and scalable, precision psychosocial support. Conclusions Women with HPV infection in Southwest China experience substantial psychosocial burden manifested as high rates of anxiety and depression, driven by HPV-specific worry, emotional and relational stressors, and provider interaction quality. High-risk genotypes and early infection stages represent critical windows for intervention. Embedding culturally adapted psychosocial screening, clinician communication training, and partner-inclusive counseling into HPV management pathways can improve quality of life and support equitable progress toward cervical cancer elimination goals. Supplementary Information Supplementary Material 1 Acknowledgements We sincerely thank all of the physicians and patients who participated in this study. We are deeply grateful to our colleagues from the Department of Gynecology, The Affiliated Hospital of Southwest Medical University, and the Department of Gynecology, People’s Hospital of Naxi District, Luzhou, for their generous support in participant recruitment, data collection, and clinical coordination. Special acknowledgment is extended to the frontline healthcare workers in Luzhou for their dedication to women’s health during the implementation of this research. Use of AI During the preparation of this work, the authors used ChatGPT solely to improve language clarity, grammar, and readability. After using these tools, the authors reviewed and edited the content as needed and took full responsibility for the scientific content and integrity of the publication. Abbreviations Human Papillomavirus General Anxiety Disorder7 Patient Health Questionnaire Human Papillomavirus Impact Profile Comparative Fit Index Root Mean Squared Error of Approximation Average Variance Extracted World Health Organization Authors’ contributions JM and ND conceptualized the study, participated in its design, oversaw research implementation, administered the survey, and drafted the manuscript. HC and YL contributed to data collection. WX and ZF performed statistical analyses. All authors reviewed and approved the final version of the manuscript. Funding Not applicable. Data availability Data and materials are available upon reasonable request. Declarations Ethics approval and consent to participate This study received ethical review and approval from the Ethics Committee of the People's Hospital of Naxi District, Luzhou City (Approval No.: 20230614KYLL016) and strictly adhered to the ethical principles outlined in the Declaration of Helsinki. Prior to questionnaire completion, written informed consent was obtained from each participant. Participants retained the right to decline participation or withdraw from the study without penalty, and all individual data were maintained in strict confidence. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement Data and materials are available upon reasonable request.